These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 802567)

  • 1. [Evaluation data from experimental series on a killed influenza vaccine purified and concentrated by differential and density gradient centrifugation. II. The results of a study of the reactogenic properties of the vaccine].
    Karpukhin GI; Popov IV; Malikova EV
    Tr Inst Im Pastera; 1976; 47():156-9. PubMed ID: 802567
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunogenic and reactogenic properties of inactivated influenza vaccine purified and concentrated by gradient centrifugation].
    Malikova EV; Safonova LS; Zueva LP; Znakova GM
    Tr Inst Im Pastera; 1982; 57():122-3. PubMed ID: 6763376
    [No Abstract]   [Full Text] [Related]  

  • 3. [Reactogenic properties and the immunological activity of an absorbed influenza chemical vaccine].
    Rudenko LG; Ishkil'din MI; Esorov PA; Ranevskiĭ VD; Zoshchenkova PIa
    Tr Inst Im Pastera; 1976; 47():160-3. PubMed ID: 802568
    [No Abstract]   [Full Text] [Related]  

  • 4. [Evaluation data from experimental series on a killed influenza vaccine purified and concentrated by differential and density gradient centrifugation. I. Laboratory evaluation data].
    Karpukhin GI; Popov IV; Malikova EV
    Tr Inst Im Pastera; 1976; 47():154-6. PubMed ID: 1052580
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunogenic study of killed influenza vaccine purified and concentrated by a chromatographic method on silica sorbents. II. The immunogenic properties of a vaccine from the A/Scotland/74 strain].
    Polzik TP; Bichurina MA; Goriunova VV; Bokhnevich GM; Polianskaia NIu
    Tr Inst Im Pastera; 1976; 47():128-33. PubMed ID: 210538
    [No Abstract]   [Full Text] [Related]  

  • 6. [1st experience with human inoculations with an inactivated influenza vaccine].
    Beliakov VD; Ivanov KG; Bundzen NG; Tentser PS; Maliarenko IuD
    Tr Inst Im Pastera; 1976; 47():114-21. PubMed ID: 802563
    [No Abstract]   [Full Text] [Related]  

  • 7. [Further study of the reactogenic properties and safety of a killed influenza A/Scotland/74 vaccine].
    Ranevskiĭ VD; Belov AB; Ivanov KG; Ishkil'din MI; Markelov IM
    Tr Inst Im Pastera; 1976; 47():121-3. PubMed ID: 802564
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunogenic study of killed influenza vaccine purified and concentrated by a chromatographic method on silicate sorbents. I. The immunogenic properties of a vaccine from the A/Victoria/72 strain].
    Malafeeva LK; Fridman EA; Zheleznova NV; Polzik TP; Ivanov KG
    Tr Inst Im Pastera; 1976; 47():124-8. PubMed ID: 210537
    [No Abstract]   [Full Text] [Related]  

  • 9. [Results of a 3-year survey of persons inoculated with inactivated influenza vaccine (IIV). I. An evaluation of its reactogenic peoperties, safety and epidemiological effectiveness].
    Mukhina LP; Kozlova NA; Rykushin IuP; Fridman EA; Bichurina MA
    Tr Inst Im Pastera; 1979; 52():65-71. PubMed ID: 162088
    [No Abstract]   [Full Text] [Related]  

  • 10. ACIP releases recommendations for use of live, attenuated influenza vaccine.
    Ressel GW;
    Am Fam Physician; 2003 Dec; 68(11):2275-6. PubMed ID: 14677671
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effectiveness of inactivated vaccines against influenza].
    Fridman EA; Peradze TV
    Tr Inst Im Pastera; 1982; 58():84-94. PubMed ID: 6764983
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinico-immunologic and allergologic studies with the inactivated influenza virus vaccine purified and concentrated by gradient centrifugation.
    Subbotina TI; Tenkova TV; Sidorova LV; Shpilyuk GF; Drinevsky VP; Voitsekhovskaya EM; Konstantinov VK; Sominina AA
    Acta Virol; 1988 Nov; 32(6):494-502. PubMed ID: 2906221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Results of a study of the technology of preparing inactivated chromatographic influenza vaccine].
    Peĭsel' SG; Nifontova AI; Bokhnevich GN; Zakharenko IV; Ermolaev AI
    Tr Inst Im Pastera; 1982; 59():65-6. PubMed ID: 7187570
    [No Abstract]   [Full Text] [Related]  

  • 14. [Properties and biological activity of inactivated influenza vaccine].
    D'iachenko AP
    Mikrobiol Zh (1978); 1982; 44(3):57-9. PubMed ID: 7121321
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experience in using an absorbed influenza chemical vaccine for the immunization of donors in producing anti-influenzal gamma-globulin].
    Egorov PA; Isupov FG; Tuĭmedova RA; Afanas'eva GA; Lobanova AM
    Tr Inst Im Pastera; 1976; 47():163-6. PubMed ID: 80045
    [No Abstract]   [Full Text] [Related]  

  • 16. Recent changes in influenza epidemiology and vaccination recommendations.
    Zimmerman RK
    J Fam Pract; 2005 Jan; 54(1 Suppl):S1-8. PubMed ID: 15623391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Live attenuated influenza vaccine in children.
    Ambrose CS; Walker RE; Connor EM
    Semin Pediatr Infect Dis; 2006 Oct; 17(4):206-12. PubMed ID: 17055372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nasal influenza vaccine enters Phase I clinical trial.
    Expert Rev Vaccines; 2007 Jun; 6(3):305. PubMed ID: 17542745
    [No Abstract]   [Full Text] [Related]  

  • 19. Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Dec; 58(48):1351-6. PubMed ID: 20010511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Method for the simultaneous immunization against influenza using inactivated and live vaccines].
    Orlov VA; Ermolaeva OM; Malikova EV; Zakharina VN; Konstantinov VK
    Tr Inst Im Pastera; 1982; 59():62-4. PubMed ID: 7187569
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.